Inventor · disambiguated record
Michael John Mackel
Also filed as: MACKEL MICHAEL J · MACKEL MICHAEL JOHN
8 granted patents·43 citations·filing 2010–2020
85Inventor score
Files withALLEGRO PHARMACEUTICALS LLC4ALLEGRO PHARMACEUTICALS INC2MACKEL MICHAEL J1MACKEL MICHAEL JOHN1
Top patents by PatentIndex Score
8 records- 0190US10307460B2Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sitesALLEGRO PHARMACEUTICALS INC·Filed 2018·Granted Jun 4, 2019·6 cites·10 claims
- 0290US9872886B2Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sitesALLEGRO PHARMACEUTICALS INC·Filed 2015·Granted Jan 23, 2018·8 cites·27 claims
- 0388US9018352B2Peptide compositions and therapeutic uses thereofMACKEL MICHAEL J·Filed 2010·Granted Apr 28, 2015·13 cites·24 claims
- 0487US10639347B2Peptides useable for treatment of disorders of the eyeALLEGRO PHARMACEUTICALS LLC·Filed 2019·Granted May 5, 2020·4 cites·16 claims
- 0583US9896480B2Integrin receptor antagonists and their methods of useMACKEL MICHAEL JOHN·Filed 2012·Granted Feb 20, 2018·9 cites·28 claims
- 0681US10590166B2Peptides useable for treating cancerALLEGRO PHARMACEUTICALS LLC·Filed 2018·Granted Mar 17, 2020·3 cites·8 claims
- 0767US11666625B2Pharmaceutical compositions and preparations for administration to the eyeALLEGRO PHARMACEUTICALS LLC·Filed 2020·Granted Jun 6, 2023·0 cites·27 claims
- 0849US11673914B2Peptide therapies for reduction of macular thickeningALLEGRO PHARMACEUTICALS LLC·Filed 2020·Granted Jun 13, 2023·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →